How important is inflammation and body weight in the origin of depression?

A new paper in BMC Medicine examines the role of inflammation and body mass index (BMI) in the etiology of treatment-resistant depression.

FDA delays assessment of BMS and 2seventy’s CAR-T therapy

Share this article Abecma was approved as a fifth-line therapy for relapsed or refractory multiple myeloma by the FDA in 2021. Image Credit: JHVEPhoto /

November 21, 2023

Ipsen files another Onivyde lawsuit two weeks after receiving new patent

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Quadruplet Shows ‘Excellent Activity’ in Myeloma Patients Who Defer HSCT

Adding the CD38 monoclonal antibody isatuximab (Sarclisa) to a backbone of carfilzomib (Kyprolis), lenalidomide (Revlimid), and dexamethasone (KRd) induced deep and durable responses in a

April 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.